Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glyceraldehyde-3-phosphate dehydrogenase pseudogene 63 (GAPDHP63) is a human pseudogene, meaning it is a sequence that resembles the gene encoding the glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH) but is non-functional and does not encode an active protein. The human genome contains multiple GAPDH pseudogenes due to gene duplication and retrotransposition events, but these pseudogenes do not contribute to normal cellular metabolism or drug response. They are sometimes notable because their sequence similarity to the functional GAPDH gene can complicate laboratory assays such as PCR and qPCR, potentially resulting in misleading expression data if not carefully controlled[1][12].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glyceraldehyde-3-phosphate dehydrogenase pseudogene 63 (GAPDHP63).